Trump's corporate tax holiday could spur pharma M&A

(Reuters) - U.S. President-elect Donald Trump's plan to incentivize U.S. companies to repatriate their swelling overseas cash piles could spur a new wave of dealmaking in a pharmaceutical industry...

from Reuters: Deals http://ift.tt/2hbrIqB
via IFTTT